Nautilus Biotechnology, Inc. (NAUT) stock
NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$2.43+0.07 (+2.97%)
Close on Nov 18, 2026Market cap $309.52MP/E –Yield –
Nautilus Biotechnology operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2021 | Mar 31, 2021 | -$1.78M | – |
| Q3 FY2020 | Sep 30, 2020 | -$174.67K | – |
See a number that looks wrong?